Success Metrics

Clinical Success Rate
90.9%

Based on 60 completed trials

Completion Rate
91%(60/66)
Active Trials
8(9%)
Results Posted
37%(22 trials)
Terminated
6(7%)

Phase Distribution

Ph phase_2
16
18%
Ph phase_3
18
20%
Ph not_applicable
9
10%
Ph phase_1
6
7%
Ph phase_4
29
33%

Phase Distribution

6

Early Stage

16

Mid Stage

47

Late Stage

Phase Distribution78 total trials
Phase 1Safety & dosage
6(7.7%)
Phase 2Efficacy & side effects
16(20.5%)
Phase 3Large-scale testing
18(23.1%)
Phase 4Post-market surveillance
29(37.2%)
N/ANon-phased studies
9(11.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

60 of 68 finished

Non-Completion Rate

11.8%

8 ended early

Currently Active

8

trials recruiting

Total Trials

88

all time

Status Distribution
Active(8)
Completed(60)
Terminated(8)
Other(12)

Detailed Status

Completed60
unknown12
Recruiting7
Terminated6
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
88
Active
8
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (7.7%)
Phase 216 (20.5%)
Phase 318 (23.1%)
Phase 429 (37.2%)
N/A9 (11.5%)

Trials by Status

recruiting78%
completed6068%
terminated67%
unknown1214%
active_not_recruiting11%
withdrawn22%

Recent Activity

Clinical Trials (88)

Showing 20 of 88 trialsScroll for more
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT03574792Phase 2

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Completed
NCT05603104Phase 3

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
NCT05973786Phase 3

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
NCT06803485Phase 4

Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder

Recruiting
NCT03532477

Bariatric Surgery and Pharmacokinetics of Venlafaxine

Recruiting
NCT04539951Phase 2

Pragmatic Trial of Obsessive-compulsive Disorder

Recruiting
NCT00667121

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Completed
NCT06106529Phase 3

REDucing Hot FLASHes in Women Using Endocrine Therapy.

Recruiting
NCT04977271Phase 4

Mood Disorders in Head and Neck Cancer Patients

Withdrawn
NCT01000623Not Applicable

Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes

Completed
NCT04446039

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Completed
NCT04218123Phase 2

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

Completed
NCT04639193Phase 2

Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

Completed
NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
NCT05724849Phase 2

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Withdrawn
NCT06131268Phase 4

The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)

Unknown
NCT05884268Phase 1

Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy

Unknown
NCT02958527

Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
88